CS logo
small CS logo
Centro de Investigacion Pergamino SA - Clinica Pergamino SA

Pergamino, Buenos Aires, Argentina

About Centro de Investigacion Pergamino SA - Clinica Pergamino SA


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Centro de Investigacion Pergamino SA - Clinica Pergamino SA


During the past decade, Centro de Investigacion Pergamino SA - Clinica Pergamino SA conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Centro de Investigacion Pergamino SA - Clinica Pergamino SA" #1 collaborator was "Astellas Pharma Inc" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

Clinical Trials Conditions at Centro de Investigacion Pergamino SA - Clinica Pergamino SA


According to Clinical.Site data, the most researched conditions in "Centro de Investigacion Pergamino SA - Clinica Pergamino SA" are "Prostate Cancer" (1 trials) and "mCRPC" (1 trials). Many other conditions were trialed in "Centro de Investigacion Pergamino SA - Clinica Pergamino SA" in a lesser frequency.

Clinical Trials Intervention Types at Centro de Investigacion Pergamino SA - Clinica Pergamino SA


Most popular intervention types in "Centro de Investigacion Pergamino SA - Clinica Pergamino SA" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo plus enzalutamide" (1 trials), "Placebo with enzalutamide" (1 trials), "Talazoparib with enzalutamide" (1 trials) and "talazoparib plus enzalutamide" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Centro de Investigacion Pergamino SA - Clinica Pergamino SA


The vast majority of trials in "Centro de Investigacion Pergamino SA - Clinica Pergamino SA" are 2 trials for "Male" genders.

Clinical Trials Status at Centro de Investigacion Pergamino SA - Clinica Pergamino SA


Currently, there are NaN active trials in "Centro de Investigacion Pergamino SA - Clinica Pergamino SA". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Centro de Investigacion Pergamino SA - Clinica Pergamino SA, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Centro de Investigacion Pergamino SA - Clinica Pergamino SA, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".